ABBOTT LABORATORIES Earnings Per Share (Diluted)
ABBOTT LABORATORIES (ABT) reported Earnings Per Share (Diluted) of $0.61 per share for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-29.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-04-29
- ABBOTT LABORATORIES earnings per share, diluted for the quarter ending 2026-03-31 was $0.61, a 19.74% decline year-over-year.
- ABBOTT LABORATORIES earnings per share, diluted for the quarter ending 2025-12-31 was $1.02, a 80.77% decline year-over-year.
- ABBOTT LABORATORIES earnings per share, diluted for the quarter ending 2025-09-30 was $0.94, a 0.00% change year-over-year.
- ABBOTT LABORATORIES earnings per share, diluted for the quarter ending 2025-06-30 was $1.01, a 36.49% increase year-over-year.
- ABBOTT LABORATORIES earnings per share, diluted for fiscal 2025 was $3.72, a 51.31% decline from fiscal 2024.
- ABBOTT LABORATORIES earnings per share, diluted for fiscal 2024 was $7.64, a 134.36% increase from fiscal 2023.
- ABBOTT LABORATORIES earnings per share, diluted for fiscal 2023 was $3.26, a 16.62% decline from fiscal 2022.
- ABBOTT LABORATORIES earnings per share, diluted for fiscal 2022 was $3.91, a 0.76% decline from fiscal 2021.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2026-03-31 | $0.61 10-Q · filed 2026-04-29 | $1.63 derived: net income ÷ weighted average shares · filed 2026-04-29 | $2.57 derived: net income ÷ weighted average shares · filed 2026-04-29 | $3.59 derived: net income ÷ weighted average shares · filed 2026-04-29 |
| 2025-12-31 | $1.02 derived: net income ÷ weighted average shares · filed 2026-02-20 | $1.96 derived: net income ÷ weighted average shares · filed 2026-02-20 | $2.97 derived: net income ÷ weighted average shares · filed 2026-02-20 | $3.72 10-K · filed 2026-02-20 |
| 2025-09-30 | $0.94 10-Q · filed 2025-10-29 | $1.96 derived: net income ÷ weighted average shares · filed 2025-10-29 | $2.70 10-Q · filed 2025-10-29 | $8.00 derived: net income ÷ weighted average shares · filed 2026-04-29 |
| 2025-06-30 | $1.01 10-Q · filed 2025-07-30 | $1.77 10-Q · filed 2025-07-30 | $7.06 derived: net income ÷ weighted average shares · filed 2026-04-29 | $8.00 derived: net income ÷ weighted average shares · filed 2026-04-29 |
| 2025-03-31 | $0.76 10-Q · filed 2026-04-29 | $6.05 derived: net income ÷ weighted average shares · filed 2026-04-29 | $6.99 derived: net income ÷ weighted average shares · filed 2026-04-29 | $7.73 derived: net income ÷ weighted average shares · filed 2026-04-29 |
| 2024-12-31 | $5.29 derived: net income ÷ weighted average shares · filed 2026-02-20 | $6.23 derived: net income ÷ weighted average shares · filed 2026-02-20 | $6.97 derived: net income ÷ weighted average shares · filed 2026-02-20 | $7.64 10-K · filed 2026-02-20 |
| 2024-09-30 | $0.94 10-Q · filed 2025-10-29 | $1.69 derived: net income ÷ weighted average shares · filed 2025-10-29 | $2.38 10-Q · filed 2025-10-29 | $3.30 derived: net income ÷ weighted average shares · filed 2026-02-20 |
| 2024-06-30 | $0.74 10-Q · filed 2025-07-30 | $1.44 10-Q · filed 2025-07-30 | $2.36 derived: net income ÷ weighted average shares · filed 2026-02-20 | $3.18 derived: net income ÷ weighted average shares · filed 2026-02-20 |
| 2024-03-31 | $0.70 10-Q · filed 2025-04-30 | $1.61 derived: net income ÷ weighted average shares · filed 2026-02-20 | $2.43 derived: net income ÷ weighted average shares · filed 2026-02-20 | $3.22 derived: net income ÷ weighted average shares · filed 2026-02-20 |
| 2023-12-31 | $0.91 derived: net income ÷ weighted average shares · filed 2026-02-20 | $1.73 derived: net income ÷ weighted average shares · filed 2026-02-20 | $2.52 derived: net income ÷ weighted average shares · filed 2026-02-20 | $3.26 10-K · filed 2026-02-20 |
| 2023-09-30 | $0.82 10-Q · filed 2024-10-31 | $1.61 derived: net income ÷ weighted average shares · filed 2024-10-31 | $2.35 10-Q · filed 2024-10-31 | $2.95 derived: net income ÷ weighted average shares · filed 2025-02-21 |
| 2023-06-30 | $0.78 10-Q · filed 2024-07-31 | $1.53 10-Q · filed 2024-07-31 | $2.13 derived: net income ÷ weighted average shares · filed 2025-02-21 | $2.94 derived: net income ÷ weighted average shares · filed 2025-02-21 |
| 2023-03-31 | $0.75 10-Q · filed 2024-05-02 | $1.34 derived: net income ÷ weighted average shares · filed 2025-02-21 | $2.16 derived: net income ÷ weighted average shares · filed 2025-02-21 | $3.30 derived: net income ÷ weighted average shares · filed 2025-02-21 |
| 2022-12-31 | $0.59 derived: net income ÷ weighted average shares · filed 2025-02-21 | $1.40 derived: net income ÷ weighted average shares · filed 2025-02-21 | $2.55 derived: net income ÷ weighted average shares · filed 2025-02-21 | $3.91 10-K · filed 2025-02-21 |
| 2022-09-30 | $0.81 10-Q · filed 2023-11-01 | $1.96 derived: net income ÷ weighted average shares · filed 2023-11-01 | $3.32 10-Q · filed 2023-11-01 | $4.45 derived: net income ÷ weighted average shares · filed 2024-02-16 |
| 2022-06-30 | $1.14 10-Q · filed 2023-08-03 | $2.51 10-Q · filed 2023-08-03 | $3.64 derived: net income ÷ weighted average shares · filed 2024-02-16 | $4.81 derived: net income ÷ weighted average shares · filed 2024-02-16 |
| 2022-03-31 | $1.37 10-Q · filed 2023-05-04 | $2.49 derived: net income ÷ weighted average shares · filed 2024-02-16 | $3.67 derived: net income ÷ weighted average shares · filed 2024-02-16 | $4.33 derived: net income ÷ weighted average shares · filed 2024-02-16 |
| 2021-12-31 | $1.12 derived: net income ÷ weighted average shares · filed 2024-02-16 | $2.29 derived: net income ÷ weighted average shares · filed 2024-02-16 | $2.95 derived: net income ÷ weighted average shares · filed 2024-02-16 | $3.94 10-K · filed 2024-02-16 |
| 2021-09-30 | $1.17 10-Q · filed 2022-11-01 | $1.84 derived: net income ÷ weighted average shares · filed 2022-11-01 | $2.83 10-Q · filed 2022-11-01 | $4.04 derived: net income ÷ weighted average shares · filed 2023-02-17 |
| 2021-06-30 | $0.66 10-Q · filed 2022-08-02 | $1.66 10-Q · filed 2022-08-02 | $2.87 derived: net income ÷ weighted average shares · filed 2023-02-17 | $3.56 derived: net income ÷ weighted average shares · filed 2023-02-17 |
| 2021-03-31 | $1.00 10-Q · filed 2022-05-03 | $2.21 derived: net income ÷ weighted average shares · filed 2023-02-17 | $2.90 derived: net income ÷ weighted average shares · filed 2023-02-17 | $3.20 derived: net income ÷ weighted average shares · filed 2023-02-17 |
| 2020-12-31 | $1.21 derived: net income ÷ weighted average shares · filed 2023-02-17 | $1.90 derived: net income ÷ weighted average shares · filed 2023-02-17 | $2.20 derived: net income ÷ weighted average shares · filed 2023-02-17 | $2.50 10-K · filed 2023-02-17 |
| 2020-09-30 | $0.69 10-Q · filed 2021-11-03 | $0.99 derived: net income ÷ weighted average shares · filed 2021-11-03 | $1.30 10-Q · filed 2021-11-03 | $1.90 derived: net income ÷ weighted average shares · filed 2022-02-18 |
| 2020-06-30 | $0.30 10-Q · filed 2021-08-04 | $0.61 10-Q · filed 2021-08-04 | $1.21 derived: net income ÷ weighted average shares · filed 2022-02-18 | $1.74 derived: net income ÷ weighted average shares · filed 2022-02-18 |
| 2020-03-31 | $0.31 10-Q · filed 2021-05-05 | $0.91 derived: net income ÷ weighted average shares · filed 2022-02-18 | $1.44 derived: net income ÷ weighted average shares · filed 2022-02-18 | $2.01 derived: net income ÷ weighted average shares · filed 2022-02-18 |
| 2019-12-31 | $0.59 10-K · filed 2020-02-21 | $1.13 derived: net income ÷ weighted average shares · filed 2022-02-18 | $1.69 derived: net income ÷ weighted average shares · filed 2022-02-18 | $2.06 10-K · filed 2022-02-18 |
| 2019-09-30 | $0.53 10-Q · filed 2020-11-04 | $1.10 derived: net income ÷ weighted average shares · filed 2020-11-04 | $1.47 10-Q · filed 2020-11-04 | $1.85 derived: net income ÷ weighted average shares · filed 2021-02-19 |
| 2019-06-30 | $0.56 10-Q · filed 2020-07-29 | $0.94 10-Q · filed 2020-07-29 | $1.31 derived: net income ÷ weighted average shares · filed 2021-02-19 | $1.63 derived: net income ÷ weighted average shares · filed 2021-02-19 |
| 2019-03-31 | $0.38 10-Q · filed 2020-04-29 | $0.75 derived: net income ÷ weighted average shares · filed 2021-02-19 | $1.06 derived: net income ÷ weighted average shares · filed 2021-02-19 | $1.48 derived: net income ÷ weighted average shares · filed 2021-02-19 |
| 2018-12-31 | $0.37 10-K · filed 2020-02-21 | $0.69 derived: net income ÷ weighted average shares · filed 2021-02-19 | $1.10 derived: net income ÷ weighted average shares · filed 2021-02-19 | $1.33 10-K · filed 2021-02-19 |
| 2018-09-30 | $0.32 10-K · filed 2020-02-21 | $0.73 derived: net income ÷ weighted average shares · filed 2020-02-21 | $0.96 10-Q · filed 2019-10-31 | $0.50 derived: net income ÷ weighted average shares · filed 2020-02-21 |
| 2018-06-30 | $0.41 10-K · filed 2020-02-21 | $0.64 10-Q · filed 2019-07-31 | $0.18 derived: net income ÷ weighted average shares · filed 2020-02-21 | $0.53 derived: net income ÷ weighted average shares · filed 2020-02-21 |
| 2018-03-31 | $0.23 10-K · filed 2020-02-21 | -$0.23 derived: net income ÷ weighted average shares · filed 2020-02-21 | $0.11 derived: net income ÷ weighted average shares · filed 2020-02-21 | $0.27 derived: net income ÷ weighted average shares · filed 2020-02-21 |
| 2017-12-31 | -$0.48 10-K · filed 2019-02-22 | -$0.13 derived: net income ÷ weighted average shares · filed 2020-02-21 | $0.03 derived: net income ÷ weighted average shares · filed 2020-02-21 | $0.27 10-K · filed 2020-02-21 |
| 2017-09-30 | $0.34 10-K · filed 2019-02-22 | $0.51 derived: net income ÷ weighted average shares · filed 2019-02-22 | $0.74 10-Q · filed 2018-10-31 | $1.25 derived: net income ÷ weighted average shares · filed 2019-02-22 |
| 2017-06-30 | $0.16 10-K · filed 2019-02-22 | $0.40 10-Q · filed 2018-08-01 | $0.91 derived: net income ÷ weighted average shares · filed 2019-02-22 | $0.73 derived: net income ÷ weighted average shares · filed 2019-02-22 |
| 2017-03-31 | $0.24 10-K · filed 2019-02-22 | $0.76 derived: net income ÷ weighted average shares · filed 2019-02-22 | $0.57 derived: net income ÷ weighted average shares · filed 2019-02-22 | $0.97 derived: net income ÷ weighted average shares · filed 2019-02-22 |
| 2016-12-31 | $0.53 10-K · filed 2018-02-16 | $0.32 derived: net income ÷ weighted average shares · filed 2019-02-22 | $0.73 derived: net income ÷ weighted average shares · filed 2019-02-22 | $0.94 10-K · filed 2019-02-22 |
| 2016-09-30 | -$0.22 10-K · filed 2018-02-16 | $0.19 derived: net income ÷ weighted average shares · filed 2018-02-16 | $0.40 10-Q · filed 2017-11-02 | $0.92 derived: net income ÷ weighted average shares · filed 2018-02-16 |
| 2016-06-30 | $0.41 10-K · filed 2018-02-16 | $0.63 10-Q · filed 2017-08-02 | $1.14 derived: net income ÷ weighted average shares · filed 2018-02-16 | $1.53 derived: net income ÷ weighted average shares · filed 2018-02-16 |
| 2016-03-31 | $0.21 10-K · filed 2018-02-16 | $0.73 derived: net income ÷ weighted average shares · filed 2018-02-16 | $1.11 derived: net income ÷ weighted average shares · filed 2018-02-16 | $1.63 derived: net income ÷ weighted average shares · filed 2018-02-16 |
| 2015-12-31 | $0.51 10-K · filed 2017-02-17 | $0.90 derived: net income ÷ weighted average shares · filed 2018-02-16 | $1.42 derived: net income ÷ weighted average shares · filed 2018-02-16 | $2.92 10-K · filed 2018-02-16 |
| 2015-09-30 | $0.38 10-K · filed 2017-02-17 | $0.91 derived: net income ÷ weighted average shares · filed 2017-02-17 | $2.41 10-Q · filed 2016-11-03 | $3.02 derived: net income ÷ weighted average shares · filed 2017-02-17 |
| 2015-06-30 | $0.52 10-K · filed 2017-02-17 | $2.03 10-Q · filed 2016-08-03 | $2.63 derived: net income ÷ weighted average shares · filed 2017-02-17 | $2.98 derived: net income ÷ weighted average shares · filed 2017-02-17 |
| 2015-03-31 | $1.51 10-K · filed 2017-02-17 | $2.10 derived: net income ÷ weighted average shares · filed 2017-02-17 | $2.46 derived: net income ÷ weighted average shares · filed 2017-02-17 | $2.77 derived: net income ÷ weighted average shares · filed 2017-02-17 |
| 2014-12-31 | $0.59 10-K · filed 2016-02-19 | $0.95 derived: net income ÷ weighted average shares · filed 2017-02-17 | $1.26 derived: net income ÷ weighted average shares · filed 2017-02-17 | $1.49 10-K · filed 2017-02-17 |
| 2014-09-30 | $0.36 10-K · filed 2016-02-19 | $0.66 derived: net income ÷ weighted average shares · filed 2016-02-19 | $0.90 10-Q · filed 2015-11-05 | $1.28 derived: net income ÷ weighted average shares · filed 2016-02-19 |
| 2014-06-30 | $0.30 10-K · filed 2016-02-19 | $0.55 10-Q · filed 2015-08-04 | $0.93 derived: net income ÷ weighted average shares · filed 2016-02-19 | $1.55 derived: net income ÷ weighted average shares · filed 2016-02-19 |
| 2014-03-31 | $0.24 10-K · filed 2016-02-19 | $0.62 derived: net income ÷ weighted average shares · filed 2016-02-19 | $1.24 derived: net income ÷ weighted average shares · filed 2016-02-19 | $1.54 derived: net income ÷ weighted average shares · filed 2016-02-19 |
| 2013-12-31 | $0.37 10-K · filed 2015-02-27 | $0.99 derived: net income ÷ weighted average shares · filed 2016-02-19 | $1.29 derived: net income ÷ weighted average shares · filed 2016-02-19 | $1.62 10-K · filed 2016-02-19 |
| 2013-09-30 | $0.61 10-K · filed 2015-02-27 | $0.92 derived: net income ÷ weighted average shares · filed 2015-02-27 | $1.25 10-Q · filed 2014-11-06 | $1.92 derived: net income ÷ weighted average shares · filed 2015-02-27 |
| 2013-06-30 | $0.30 10-K · filed 2015-02-27 | $0.64 10-Q · filed 2014-08-05 | $1.31 derived: net income ÷ weighted average shares · filed 2015-02-27 | $2.53 derived: net income ÷ weighted average shares · filed 2015-02-27 |
| 2013-03-31 | $0.34 10-K · filed 2015-02-27 | $1.00 derived: net income ÷ weighted average shares · filed 2015-02-27 | $2.22 derived: net income ÷ weighted average shares · filed 2015-02-27 | $3.31 derived: net income ÷ weighted average shares · filed 2015-02-27 |
| 2012-12-31 | $0.66 10-K · filed 2014-02-21 | $1.88 derived: net income ÷ weighted average shares · filed 2015-02-27 | $2.96 derived: net income ÷ weighted average shares · filed 2015-02-27 | $3.72 10-K · filed 2015-02-27 |
| 2012-09-30 | $1.21 10-K · filed 2014-02-21 | $2.30 derived: net income ÷ weighted average shares · filed 2014-02-21 | $3.06 10-Q · filed 2013-11-07 | |
| 2012-06-30 | $1.08 10-K · filed 2014-02-21 | $1.85 10-Q · filed 2013-08-06 | ||
| 2012-03-31 | $0.78 10-K · filed 2014-02-21 | |||
| 2011-12-31 | $1.02 10-K · filed 2013-02-15 | $3.01 10-K · filed 2014-02-21 | ||
| 2011-09-30 | $0.19 10-K · filed 2013-02-15 | $1.98 10-Q · filed 2012-11-07 | ||
| 2011-06-30 | $1.23 10-K · filed 2013-02-15 | $1.79 10-Q · filed 2012-08-07 | ||
| 2011-03-31 | $0.55 10-K · filed 2013-02-15 | |||
| 2010-12-31 | $0.92 10-K · filed 2013-02-15 | $2.96 10-K · filed 2013-02-15 | ||
| 2010-09-30 | $0.57 10-K · filed 2013-02-15 | $2.04 10-Q · filed 2011-11-04 | ||
| 2010-06-30 | $0.83 10-K · filed 2013-02-15 | $1.47 10-Q · filed 2011-08-04 | ||
| 2010-03-31 | $0.64 10-K · filed 2013-02-15 | |||
| 2009-12-31 | $0.98 10-K · filed 2012-02-21 | $3.69 10-K · filed 2012-02-21 | ||
| 2009-09-30 | $0.95 10-K · filed 2012-02-21 | $2.70 10-Q · filed 2010-11-05 | ||
| 2009-06-30 | $0.83 10-K · filed 2012-02-21 | $1.75 10-Q · filed 2010-08-05 | ||
| 2009-03-31 | $0.92 10-K · filed 2012-02-21 | |||
| 2008-12-31 | $0.98 10-K · filed 2011-02-18 | $3.12 10-K · filed 2011-02-18 | ||
| 2008-09-30 | $0.69 10-K · filed 2011-02-18 | $2.14 10-Q · filed 2009-11-06 | ||
| 2008-06-30 | $0.85 10-K · filed 2011-02-18 | $1.45 10-Q · filed 2009-08-07 | ||
| 2008-03-31 | $0.60 10-K · filed 2011-02-18 | |||
| 2007-12-31 | $2.31 10-K · filed 2010-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |